Cynosure Inc (CYNO)

66.30
NASDAQ : Health Care
Prev Close 66.25
Day Low/High 66.20 / 66.40
52 Wk Low/High 38.01 / 66.65
Avg Volume 1.02M
Exchange NASDAQ
Shares Outstanding 23.77M
Market Cap 1.57B
EPS 0.70
P/E Ratio 51.76
Div & Yield N.A. (N.A)

Latest News

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cynosure, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cynosure, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

CYNOSURE, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes The Acquisition By Hologic, Inc. May Be Unfair To Shareholders

CYNOSURE, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes The Acquisition By Hologic, Inc. May Be Unfair To Shareholders

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of CynoSure, Inc.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cynosure, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cynosure, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

Wall Street Smashes Records for Fourth Day in a Row After Rocky Session

Wall Street Smashes Records for Fourth Day in a Row After Rocky Session

Wall Street smashes records again on Tuesday, closing at all-time highs for its fourth consecutive session.

Stocks Find Upward Momentum Again as Chances of a Rate Hike Rise

Stocks Find Upward Momentum Again as Chances of a Rate Hike Rise

Wall Street hold small gains on Tuesday after Federal Reserve Chair Janet Yellen plays the part of both dove and hawk.

Stocks Mixed as Fed's Yellen Talks Rates on Capitol Hill

Stocks Mixed as Fed's Yellen Talks Rates on Capitol Hill

Wall Street is mixed on Tuesday morning after Federal Reserve Chair Janet Yellen champions the strength of the U.S. economy.

Hologic To Acquire Cynosure, Leader In Medical Aesthetics Systems And Technologies, In All-Cash Tender Offer That Combines Two Complementary Businesses

Hologic To Acquire Cynosure, Leader In Medical Aesthetics Systems And Technologies, In All-Cash Tender Offer That Combines Two Complementary Businesses

-Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate -

Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open

Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open

Other movers included Mannkind, Perrigo and Bristol-Myers Squibb.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AN, CYNO, JOB, MJCO, NYT Downgrades: None Initiations: MOXC Read on to get TheStreet Quant Ratings' detailed report:

Short Interest In Cynosure Jumps 13.6%

Short Interest In Cynosure Jumps 13.6%

The most recent short interest data has been released for the 11/30/2016 settlement date, which shows a 314,474 share increase in total short interest for Cynosure Inc , to 2,630,860, an increase of 13.58% since 11/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Cynosure Receives CFDA Clearance To Market The Icon™ Aesthetic System In China

Cynosure Receives CFDA Clearance To Market The Icon™ Aesthetic System In China

State-of-the-Art Product Enables Aesthetic Practices to Offer the Most Popular Non-Invasive Skin Treatments in a Single Platform

Short Interest In Cynosure Expands By 16%

Short Interest In Cynosure Expands By 16%

The most recent short interest data has been released for the 11/15/2016 settlement date, which shows a 317,074 share increase in total short interest for Cynosure Inc , to 2,316,386, an increase of 15.86% since 10/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Bearish Bets: A Pipeline Giant, a Chicken Seller and Other Stocks That Look Good Short

VLP, REG, CYNO, PPG and TSNU all were recently downgraded by TheStreet's Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BYD, CMO, DL, FF, FOXA, HURC, KN, NRP, NTAP, SCKT, VIAV Downgrades: CYNO, NTIC, REG Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Cynosure To Participate In Stifel 2016 Healthcare Conference

Cynosure To Participate In Stifel 2016 Healthcare Conference

Fireside Chat to be Webcast Live at 8:00 a.m. (ET) Wednesday, November 16

Cynosure Promotes Doug Delaney To Chief Commercial Officer

Cynosure Promotes Doug Delaney To Chief Commercial Officer

Company's Executive VP of Worldwide Sales Expands Leadership Role

'Mad Money' Lightning Round: Shopify's Too High Right Now, Jim Cramer Says

'Mad Money' Lightning Round: Shopify's Too High Right Now, Jim Cramer Says

Jim Cramer urges caution on SHOP, FEYE and PAY, but likes PFPT and NVDA.

Jim Cramer's 'Mad Money' Recap: When 'Not So Bad' Is Actually Pretty Good

Jim Cramer's 'Mad Money' Recap: When 'Not So Bad' Is Actually Pretty Good

Jim Cramer says results can look better when you're expecting the worst.

Cynosure To Name Stephen J. Webber As New Chief Financial Officer

Cynosure To Name Stephen J. Webber As New Chief Financial Officer

Former EMC Executive Brings 20 Years of International Finance and Business Experience to Support Cynosure's Global Growth Strategy

Short Interest Falls 16% For CYNO

Short Interest Falls 16% For CYNO

The most recent short interest data has been released for the 07/29/2016 settlement date, which shows a 255,316 share decrease in total short interest for Cynosure Inc , to 1,338,942, a decrease of 16.01% since 07/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Looking for Healthcare Stocks? Consider These Four

Looking for Healthcare Stocks? Consider These Four

These four small-cap stocks would be a healthy addition to your portfolio, says David Swank, portfolio manager for the Hood River Small-Cap Growth Fund.

TheStreet Quant Rating: B (Buy)